The overall case-hospitalization rate among patients was 5.7%.
Study suggests medical masks may offer similar protecion as N95 respirators, but experts say hold on.
Public health professionals use some terms imprecisely, others incorrectly, and still others technically accurate but almost sure to be misunderstood by the public.
Get weekly COVD-19 updates in your inbox.
Catch the latest episode!
Top COVID FAQs
By CIDRAP & other experts
Up-to-date COVID-19 data
A survey of US registered dental hygienists reported that 3.1% had been diagnosed as having COVID-19 as of October 2020, according to a Journal of Dental Hygiene study published yesterday. At the time, the study says an estimated 2.3% of the general US population had been infected.
Two doses were 92% effective in preventing infection, but 1 dose was 74% effective against COVID-related hospitalization and 72% effective at preventing death.
In other good news, the CDC says case levels have dropped to summertime levels.
In other developments, global COVID-19 cases fell for the sixth week in a row.
Americans with COVID-19 antibodies displayed 10-fold increased protection against infection 90 days after testing compared with those who had no antibodies, according to a study published today in JAMA Internal Medicine.
Pending FDA approval, Johnson & Johnson is prepared to deliver 100 million doses by mid-summer.
The authors say the data support the CDC's prioritization of this group for vaccination.
Elsewhere, the UK says new cases involving SARS-CoV-2 variants are dropping sharply.
Patients critically ill with COVID-19 infections had significantly lower levels of antibodies against seasonal human coronaviruses (HCoVs) OV43 and HKU1 than those with mild to severe infections, according to a German study published yesterday in the International Journal of Infectious Diseases.
It took only 1 month for the nation's death tally to grow from 400,000 to 500,000.